Mantle cell lymphoma

You have access
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
JUN HO YI, SEOK JIN KIM, JEONG-OK LEE, GYEONG-WON LEE, JAE-YONG KWAK, HYEON-SEOK EOM, JAE-CHEOL JO, YOON SEOK CHOI, SUNG YONG OH and WON SEOG KIM

Anticancer Research December 2022, 42 (12) 6083-6089; DOI: https://doi.org/10.21873/anticanres.16120
You have access
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
NADEZHDA ROMANCHIKOVA and PETERIS TRAPENCIERIS

Anticancer Research August 2019, 39 (8) 4179-4184; DOI: https://doi.org/10.21873/anticanres.13577
You have access
A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma
NADEZHDA ROMANCHIKOVA, ARNIS STRODS, JULIJA STRAZDINA, BORISS STRUMFS and PETERIS TRAPENCIERIS

Anticancer Research November 2016, 36 (11) 6133-6140;
You have access
Synergistic Cytotoxicity of Bendamustine and the BTK Inhibitor in a Mantle Cell Lymphoma Cell Line
KAZUMI HAGIWARA, TAKASHI TOKUNAGA, HIROATSU IIDA and HIROKAZU NAGAI

Anticancer Research December 2015, 35 (12) 6679-6684;
You have access
Second Primary Malignancies in Mantle Cell Lymphoma: A U.S. Population-based Study
BINAY KUMAR SHAH and AMIT KHANAL

Anticancer Research June 2015, 35 (6) 3437-3440;

Main menu